SUMMARY Nineteen families were selected for study in which hypertrophic cardiomyopathy and/or isolated asymmetric septal hypertrophy occurred in successive generations. All 19 propositi had hypertrophic cardiomyopathy proven by cardiac catheterisation and angiocardiography (eight), operation (four), or necropsy (seven). These 19 families consisted of the 19 propositi and their 39 siblings, 38 parents, and 23 children. Of these 119, 114 were examined or, if dead before the study, there was sufficient evidence from necropsy or operation reports to establish the diagnosis. In five (four parents and one sibling) who had died before the study there was insufficient evidence to establish the presence or absence of heart disease. These 19 families were selected from over one hundred cases of familial cardiomyopathy with a minimum follow up of five years. The main points leading to selection were the presence of the disease in two successive generations and the availability of the 'first degree relatives for examination.
versely, parents with isolated asymmetric septal hypertrophy can produce children with either anomaly. In all circumstances other than hypertrophic cardiomyopathy, asymmetric septal hypertrophy does not appear to be an inherited characteristic.
Asymmetric septal hypertrophy can no longer be considered the "unifying link" in hypertrophic cardiomyopathy. I It occurs in a small percentage of normal adults, is common in infants,23 may be present in athletes,4 and it is also seen in cases of congenital heart disease, particularly where the right ventricle is involved.5-9 It is not uncommon in fixed aortic valve stenosis7 I0 and it also occurs in hypertension"I and coronary artery disease, especially with inferior infarction. 12 13 Conversely, it is occasionally absent in cases of hypertrophic cardiomyopathy where the disarrayed muscle involves the free wall of the left ventricle as extensively as the interventricular septum. [14] [15] [16] Confusion will arise if the term asymmetric septal hypertrophy is used synonymously with hypertrophic cardiomyopathy. It is suggested that the latter should be used to describe cases with clinical, radiological, electrocardiographic, and echocardiographic evidence of the disease, which will include asymmetric hypertrophy of the interventricular septum. The term asymmetric septal hypertrophy, qualified by the word isolated, should be confined to those cases where the sole abnormality is in the interventricular septum, detected only by echocardiography, and where there is no clinical, radiological, or electrocardiographic evidence of cardiovascular disease.
The problem is exemplified by Clark et al. 17 who referred to 44 first degree relatives with asymmetric septal hypertrophy. In 77% there were abnormalities in the history, physical examination, or electrocardiogram, but in the remaining 23% the abnormalities were confined to the interventricular septum. Similarly, in 27 first degree relatives reported by Van Dorp et al. 18 and referred to as having asymmetric septal hypertrophy, 83% were clinically affected, but in 17% the abnormality was confined to the interventricular septum. The same was the case with the first degree relatives reported by Ten Cate et al. 19 where only the minority had abnormalities confined to the interventricular septum.
In this study a differentiation has been made between relatives with clinical, radiological, electrocardiographic, and echocardiographic evidence of hypertrophic cardiomyopathy and those in whom the only abnormality was in the interventricular septum, detected solely by echocardiography. The term isolated asymmetric septal hypertrophy has been confined to the latter. An interventricular septum to posterior left ventricular wall (IVS/PLVW) ratio of 1-3 or more was considered abnormal when allowance had been made for the thickening of the interventricular septum which occurs with age.211- 22 The purpose of this study was to examine the association of isolated asymmetric septal hypertrophy and its relation to hypertrophic cardiomyopathy in selected families.
Subjects and methods
Nineteen families were selected for study in which the propositus had hypertrophic cardiomyopathy proven by cardiac catheterisation and angiocardiography (eight), operation (four), or necropsy (seven). These were divided into two subsets. In the first there were 12 families where not only the propositus but also one of the parents had all the clinical, radiological, electrocardiographic, and echocardiographic manifestations of hypertrophic cardiomyopathy. In Table 3 were considered normal after clinical examination which included an electrocardiogram and chest radiograph, but after the echocardiogram had been found abnormal these data were reviewed. In two relatives there were minor abnormalities which had previously been accepted as normal, mainly on account of the patients' ages, but in retrospect these findings were probably related to the abnormal interventricular septum before accepting ratios of 1*3 or more above this age as being abnormal.
In the 12 families where not only the propositus but one parent had hypertrophic cardiomyopathy, one of the siblings had isolated asymmetric septal hypertrophy. Conversely, in the seven families where the propositus had hypertrophic cardiomyopathy and one of the parents isolated asymmetric septal hypertrophy, the seven propositi and six of their siblings had hypertrophic cardiomyopathy and only one sibling had isolated asymmetric septal hypertrophy. Therefore, a parent with either clinical hypertrophic cardiomyopathy or isolated asymmetric septal hypertrophy may produce an offspring with either manifestation of the disease, that is hypertrophic cardiomyopathy or isolated asymmetric septal hypertrophy.
In these 19 families there were 23 children. Assuming a dominant inheritance the expected number affected would be 11-5, but only three were found to have hypertrophic cardiomyopathy and two isolated asymmetric septal hypertrophy both of whom may also have bicuspid aortic valves as the echocardiograms showed eccentric aortic valve closure and in one (77.III.2) there was also a soft aortic diastolic murmur. (In 33.III.4 and 72.III.1 the diagnosis was doubtful and these children have therefore been considered normal in the statistical analysis.) The figure of five (three with hypertrophic cardiomyopathy and two with isolated asymmetric septal hypertrophy) does not differ significantly from the expected number (X2 = 2-8), though it is low, which may be because of underdiagnosis. The explanation for this in the younger age group is discussed elsewhere30 but we have increasing evidence that, though the disease is genetically determined, its clinical manifestations may not be evident until adolescence, or even early adult life. A good example of this was Family 99. When first seen 99.II.1 and 99.II.2 were aged 11 and 9 years. They were asymptomatic, the cardiovascular findings were normal, in particular there were no murmurs, and both the electrocardiograms and chest radiographs were normal. Echocardiography was not available. When examined eight years later because the younger (99.II.2) had had a synocopal attack while playing football, both had developed ejection murmurs. The electrocardiograms had become abnormal; in the younger (99.II.2) there was T wave inversion in the left chest leads and equivalents, and in the elder (99.II.1) pathological Q waves had developed in I, aVL, V5, and 6. Their chest radiographs had remained normal. The echocardiograms, previously unrecorded, were abnormal; in both there was a thickened immobile interventricular septum and the younger also showed systolic anterior movement of the mitral valve. The IVS/PLVW ratio was 1X4. Five years after this examination he died suddenly at the age of 22 years. The diagnosis of hypertrophic cardiomyopathy was confirmed at necropsy, the heart weighing 430 g. The interventricular septum measured 33 mm compared with the free wall of the left ventricle which was 20 mm. The echocardiogram in the elder (99.II.1) when aged 19 years showed an immobile and abnormally thick interventricular septum measuring 13 to 14 mm. There was also thickening of the posterior left ventricular wall 11 to 12 mm giving an IVS/PLVW ratio of 12 which was within normal limits. After the inhalation of amyl nitrate, however, there was systolic anterior movement of the mitral valve. In this case the thickening of the posterior left ventricular wall tended to make the ventricular hypertrophy more symmetrical than usual, which is known to occur in some cases of hypertrophic cardiomyopathy. All causes of symmetrical hypertrophy such as hypertension and aortic valve stenosis had been excluded and the diagnosis of hypertrophic cardiomyopathy was strongly supported in this case by the development of murmurs between the ages of 11 and 19 years, the changes in the electrocardiograms during the same period, and the strongly positive family history: his brother, father, and father's sister all had proven hypertrophic cardiomyopathy.
It is uncertain whether some genetically determined cases of isolated asymmetric septal hypertrophy, that is those occurring in families in which there are no known cases of hypertrophic cardiomyopathy, progress and develop the full clinical picture of hypertrophic cardiomyopathy. There is some evidence that this may occur in children and in young adults, but after the age of 20 we have not seen isolated asymmetric septal hypertrophy alter with the years.
GENETICS
The fundamental problem is the genetic relation between asymmetric septal hypertrophy and hypertrophic cardiomyopathy. A survey of the published reports on the inheritance of asymmetric septal hypertrophy '8 1931 showed that the data have been ascertained through families in which there were proven cases of hypertrophic cardiomyopathy. Only Marcomichelakis et al.22 studied the normal population and looked at asymmetric septal hypertrophy in those subjects who were at the extreme of the distribution of septal thickness when allowance had been made for their age. Their findings confirmed that asymmetric septal hypertrophy was non-specific for hypertrophic cardiomyopathy.
The simplest genetic concept would be a single autosomal dominant gene which could be expressed in a mild (isolated asymmetric septal hypertrophy) or severe (hypertrophic cardiomyopathy) form. The problem, however, of the variation of expression within a family would remain unanswered. It could be postulated that there was either a gene for asymmetric septal hypertrophy which with genetic or environmental modifiers could be expressed as hypertrophic cardiomyopathy or, conversely, that there was a gene for hypertrophic cardiomyopathy which, with other genetic or environmental modifiers, could be expressed as isolated asymmetric septal hypertrophy. Whichever is the case the net effect is that the hypertrophic cardiomyopathy expression behaves like an autosomal dominant condition. Until a genetic study of asymmetric septal hypertrophy is done in its own right nothing can be said about its mode of inheritance. The suggestion that more than one factor is involved would fit the threshold model proposed by a number of authors in other conditions.3233 Indeed there is evidence that part of the underlying liability for hypertrophic cardiomyopathy might be related to the HLA-DRW4 antigen linkage. 34 The delayed clinical expression of hypertrophic cardiomyopathy in many cases and the fact that there is some evidence that isolated asymmetric septal hypertrophy may progress to hypertrophic cardiomyopathy suggest that the liability to asymmetric septal hypertrophy may be part of the underlying predisposition. It also suggests that the threshold for asymmetric septal hypertrophy is just below that for hypertrophic cardiomyopathy. Under these conditions such a complex genetic aetiology may simulate dominance.
By definition all patients with hypertrophic cardiomyopathy had asymmetric septal hypertrophy. If hypertrophic cardiomyopathy represents the increased severity of liability then both isolated asymmetric septal hypertrophy and hypertrophic cardiomyopathy may occur in the same family. This was the case in both the subsets studied and it would also explain the much greater incidence of hypertrophic cardiomyopathy than isolated asymmetric septal hypertrophy in any affected generation.
Our conclusion is that when a patient presents with isolated asymmetric septal hypertrophy if there is hypertrophic cardiomyopathy in the family, then either of them may be expected in 500/o of the offspring. Any minor deviations from 500/o are what one might expect from a complex trait simulating dominance. 
